logo
logo
SIGNAL-DRIVEN SALES

Turn Funding Signals into Pipeline

Fundz analyzes real-time funding events through YOUR lens to surface companies most likely to buy — with the “why now” built in.

10–25 ICP-matched leads daily • Buyer-intent scoring • No duplicates
Every plan includes:
✓Signal-Driven Leads Based on YOUR ICP
✓Slack + Chrome real-time alerts
✓No duplicates — only new events
INDUSTRY FIRST

Nanopath Inc. received $4m in federal funding to support the development of its point-of-care diagnostic platform for women’s health.

May 21, 2024•over 1 year ago

Amount Raised

$4 Million

Round Type

seed

CambridgeBiotechnologyHealth Care

Description

Nanopath Inc., a point-of-care diagnostics company, received $4m in federal funding from the National Institutes of Health (NIH) and the National Science Foundation (NSF) through the Small Business Innovation Research (SBIR) Program. The funding will support the development of its point-of-care diagnostic platform for women’s health.

Company Information

Company

Nanopath

Location

Cambridge, Massachusetts, United States

About

Nanopath is a molecular diagnostics company disrupting traditional testing methodologies. We aim to improve the health of women by providing granular and clinically actionable information within a single office visit.

FundzWatch™ Score

60
Medium Activity

Related People

Sign in to view contact details

Sign in to view contact details